Clinical Care

In a July 10 letter, the U.S. Food and Drug Administration (FDA) noted that the U.S. is experiencing interruptions in the supply of BD BACTEC blood culture media bottles because of recent supplier issues. The disruption is expected to impact patient diagnosis, follow-up patient management, and antimicrobial stewardship efforts. The FDA recommends laboratories and health care providers consider conservation strategies to prioritize the use of blood culture media bottles, preserving the supply for patients at highest risk. 

A collaborative presentation will be provided by the San Diego County Substance Use and Overdose Prevention Taskforce’s Community Resilience Committee on Aug. 5 from 9-10:30 a.m. The training will focus on stimulant use disorder in adults, current trends, and available resources, and is designed for prevention providers, treatment specialists, and health care professionals.

The H3SD: San Diego’s Heat and Human Health Summit, a climate- and health-focused event hosted by the UC San Diego School of Medicine and Kaiser Permanente, will feature an educational poster session on Aug. 16 and the summit on Aug. 17 at UC San Diego. Registration is open, and continuing medical education credits are available. 

The Food and Drug Administration (FDA) is launching the Prescribe with Confidence campaign to destigmatize medication-assisted treatment (MAT) for opioid use disorder (OUD) in primary care settings. OUD is a chronic health condition, which is treatable with medication in a variety of practice settings, including primary care. An estimated 6.1 million people in the U.S. aged 12 or older have OUD, which is often unrecognized in primary care settings. For resources that support MAT, visit the FDA’s campaign web page.